Caldwell Sutter Capital »

Celldex Therapeutics shares owned by Caldwell Sutter Capital

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Caldwell Sutter Capital from 13F filings

Historical chart of Caldwell Sutter Capital investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Caldwell Sutter Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Caldwell Sutter Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $15k 350 41.97
2023-12-31 $14k 350 39.66
2023-09-30 $9.6k 350 27.52
2023-06-30 $12k 350 33.93
2023-03-31 $13k 350 35.98
2022-12-31 $16k 350 44.57